Frank Shannon

Frank Shannon

Nessuna posizione attualmente
Health Technology
Technology Services
Finance

Profilo

Frank Shannon worked as Principal at Ciba-Geigy Corp., Genentech, Inc., TearLab Corp., Inc., Hoffmann-La Roche, Inc., Boehringer Ingelheim Corp., i3 Innovus, and TearLab Corp., Inc. Served as Vice President-Clinical & Regulatory Affairs at Interface Biologics, Inc. Held the position of VP-Clinical Development & Regulatory Affairs at Ripple Therapeutics Corp.
From 2021 to 2025, served as Vice President-Clinical Development & Regulatory at Sernova Biotherapeutics, Inc.

Precedenti posizioni note di Frank Shannon

SocietàPosizioneFine
SERNOVA BIOTHERAPEUTICS INC Direttore Tecnico/Scientifico/R&S 01/07/2025
Consigliere Generale -
Corporate Officer/Principal -
Corporate Officer/Principal -
Corporate Officer/Principal -
Vedi nel dettaglio l'esperienza di Frank Shannon

Esperienze
Posizioni ricoperte

Attive

Inattive

Società nel listino

Aziende private

Relazioni

2

Relazioni di 1° grado

9

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Società collegate

Aziende private9

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Technology Services

Finance

Health Technology

  1. Mercati
  2. Insiders
  3. Frank Shannon